角膜再生治疗综述
角膜三层结构各具维持视觉功能的关键特性,缘干细胞丢失可致角膜盲,基质破坏或内皮永久损伤需角膜移植,但供体短缺、排斥与移植物存活约10-20年限制疗效。本综述汇总角膜再生医学的重要进展,包括各类干细胞、分泌组/外泌体营养因子及角膜感觉神经再生,并展望临床转化方向。
要点
- 缘干细胞丢失可致严重角膜表面异常和角膜盲。
- 角膜基质或内皮永久损伤可移植治疗,但供体短缺且移植物平均存活10-20年。
- 再生策略涵盖角膜基质干细胞、缘干细胞、胚胎干细胞、其他成体干细胞及诱导多能干细胞。
核心结论
- 角膜再生医学为损伤或疾病后角膜重建提供了新策略,涵盖多种干细胞、干细胞来源营养因子及感觉神经再生。
研究设计与样本
- 本文为综述,汇总角膜再生医学领域的重要进展,未报告系统检索范围。
主要发现
- 角膜上皮可通过细胞分裂快速修复损伤,但缘干细胞丢失可导致严重角膜表面异常和角膜盲。
- 角膜基质细胞外基质破坏及角膜细胞丢失导致角膜混浊。
- 角膜内皮无自我更新能力,对维持角膜脱水和透明至关重要。
- 角膜移植存在供体短缺、需持续治疗防排斥及移植物平均存活10-20年的局限。
- 再生策略包括角膜基质干细胞、角膜缘干细胞、胚胎干细胞、其他成体干细胞、诱导多能干细胞,以及分泌组或外泌体形式的干细胞来源营养因子和促进角膜透明的角膜感觉神经再生。
关键数值与推荐
- 角膜移植物平均存活10-20年。
临床怎么用
- 对于缘干细胞丢失、基质破坏或内皮永久损伤等角膜盲高风险情况,可关注干细胞、营养因子及神经再生等再生医学策略的临床转化进展。
局限性
- 本文为综述,未报告系统检索范围。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The cornea is the outmost layer of the eye, unique in its transparency and strength. The cornea not only transmits the light essential for vision, also refracts light, giving focus to images. Each of the three layers of the cornea has properties essential for the function of vision. Although the epithelium can often recover from injury quickly by cell division, loss of limbal stem cells can cause severe corneal surface abnormalities leading to corneal blindness. Disruption of the stromal extracellular matrix and loss of cells determining this structure, the keratocytes, leads to corneal opacity. Corneal endothelium is the inner part of the cornea without self-renewal capacity. It is very important to maintain corneal dehydration and transparency. Permanent damage to the corneal stroma or endothelium can be effectively treated by corneal transplantation; however, there are drawbacks to this procedure, including a shortage of donors, the need for continuing treatment to prevent rejection, and limits to the survival of the graft, averaging 10-20 years. There exists a need for new strategies to promote regeneration of the stromal structure and restore vision. This review highlights critical contributions in regenerative medicine with the aim of corneal reconstruction after injury or disease. These approaches include corneal stromal stem cells, corneal limbal stem cells, embryonic stem cells, and other adult stem cells, as well as induced pluripotent stem cells. Stem cell-derived trophic factors in the forms of secretomes or exosomes for corneal regeneration are also discussed. Corneal sensory nerve regeneration promoting corneal transparency is discussed. This article provides description of the up-to-date options for corneal regeneration and presents exciting possible avenues for future studies toward clinical applications for corneal regeneration.
引用
- Kumar A, Yun H, Funderburgh ML, et al. Regenerative therapy for the Cornea. Prog Retin Eye Res. 2021. PMID: 34530154. doi:10.1016/j.preteyeres.2021.101011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。